Skip to content

European Registry for Robin sequence

European Registry for Robin sequence - ERR

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025365
Enrollment
300
Registered
2021-07-13
Start date
2022-01-08
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ORPHA:138044 Q87.0

Interventions

Group 1: Registry for the prospective evaluation of children with Robin sequence in various European health care centres specialised in the treatment of Robin sequence. The registry is an observationa

Sponsors

Tuebingen University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Months

Inclusion criteria

Inclusion criteria: - Diagnosis of Robin sequence (isolated or syndrome-associated), a combination of glossoptosis, micrognathia and upper airway obstruction ? all three criteria must be met - Age at inclusion maximum 12 month - Any gestational age and any sex - Parent or guardian, who provided consent

Exclusion criteria

Exclusion criteria: Participants whose parents/guardians are unable to understand the study protocol or are unable to give informed consent, for example due to a language barrier.

Design outcomes

Primary

MeasureTime frame
Objective of the registry is to collect data on characteristics, applied therapy, adverse events, medical follow-up and outcome of children with Robin sequence, with the intention to gain a better understanding of Robin sequence and its therapeutic options an outcomes.

Secondary

MeasureTime frame
The registry intents to • to collect more information about the disease. • to improve the quality of currently applied treatment options. • to determine the frequency of complications and adverse events. • to compare diagnostic and therapeutic procedures in affected patients across Europe. • to evaluate the effects of the different therapy options using several parameters such as MOA(H)I or z-scores at different time points. • to determine the long-term prognosis of the condition. • to generate a database for future research questions. • to enhance international cooperation.

Countries

France, Germany, Netherlands, Switzerland, United Kingdom

Contacts

Public ContactMargret Fritz, B.A.

Center for Cleft Palate & Craniofacial Malformations; Tübingen University Hospital

robinregistry@med.uni-tuebingen.de+49 7071 29-84742

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026